Impact of Microablative Fractional CO₂ Laser Applied in Menopausal Period on Vulvovaginal Atrophy and Dyspareunia: A Systematic Review and Meta-analysis Study

Ayşe Çuvadar 1 * , Handan Özcan 2, Yeter Çuvadar Baş 3
More Detail
1 Department of Midwifery, Faculty of Health Sciences, Karabuk University, Karabuk, Turkey
2 Department of Midwifery, Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey
3 Department of Paramedic, Gedik Vocational School, T.C. Gedik University, Istanbul, Turkey
* Corresponding Author
J CLIN MED KAZ, Volume 23, Issue 3, pp. 31-39. https://doi.org/10.23950/jcmk/18598
OPEN ACCESS 278 Views 117 Downloads
Download Full Text (PDF)
Author Contributions: Conceptualization, A.Ç, H.Ö; methodology, A.Ç. H.Ö, Y.Ç.B; validation, A.Ç, H.Ö, Y.Ç.B; formal analysis, A.Ç. H.Ö; investigation, A.Ç. H.Ö, Y.Ç.B; resources, A.Ç. H.Ö, Y.Ç.B; data curation, A.Ç. H.Ö, Y.Ç.B; writing – original draft preparation, A.Ç. H.Ö, Y.Ç.B; writing – review and editing, A.Ç. H.Ö, Y.Ç.B; visualization, A.Ç. H.Ö, Y.Ç.B; supervision, A.Ç. H.Ö, Y.Ç.B; project administration, A.Ç. H.Ö, Y.Ç.B; funding acquisition, A.Ç. H.Ö, Y.Ç.B. All authors have read and agreed to the published version of the manuscript.

Data availability statement: The corresponding author can provide the data supporting the study's conclusions upon request. Due to ethical and privacy constraints, the data are not publicly accessible.

Artificial Intelligence (AI) Disclosure Statement: The authors confirm that generative artificial intelligence (AI) or AI-assisted technologies were not used in the design, data analysis, interpretation, writing, or editing of this manuscript. The entire manuscript was developed and finalized by the authors.

ABSTRACT

Aim: This study aimed to synthesize current evidence on the clinical effectiveness of microablative fractional CO₂ laser (MFCO₂) therapy for the management of menopausal vulvovaginal atrophy and dyspareunia.
Methods: A meta-analysis was conducted to identify relevant studies published within the last ten years. Electronic database searches were performed between March and June 2024 using PubMed, EBSCOhost, Web of Science, Google Scholar, and the YÖK National Thesis Center. Following the screening process and eligibility evaluation according to established inclusion criteria, eight studies were ultimately retained for analysis. The methodological rigor of the selected studies was evaluated using design-specific critical appraisal instruments developed by the Joanna Briggs Institute (JBI). Quantitative data synthesis was performed using CMA Version 2 software, and findings were interpreted using both statistical meta-analytic techniques and descriptive synthesis.
Results: The pooled analysis demonstrated that MFCO₂ laser therapy produced a statistically significant improvement in vulvovaginal atrophy among menopausal women (SMD: 1.437, 95% CI: 0.646–2.228; Z = 3.559, p < 0.001; I² = 94.93%). Similarly, treatment was associated with a significant reduction in dyspareunia severity (SMD: −1.820, 95% CI: −3.063 to −0.577; Z = −2.871, p = 0.004; I² = 96.17%). These findings indicate that MFCO₂ laser therapy may contribute to meaningful symptom improvement in menopausal genitourinary disorders. However, considerable heterogeneity among included studies suggests variability in intervention protocols, patient characteristics, and outcome assessment methods.
Conclusion: Microablative fractional CO₂ laser therapy may serve as a beneficial non-hormonal intervention for improving menopausal genitourinary symptoms, especially dyspareunia among sexually active women. Nevertheless, large-scale clinical trials with uniform treatment protocols and longer follow-up are needed to confirm long-term therapeutic efficacy and safety.
Keywords: Dyspareunia, microablative fractional CO2 laser, vulvovaginal atrophy, menopause.

CITATION

Çuvadar A, Özcan H, Çuvadar Baş Y. Impact of Microablative Fractional CO₂ Laser Applied in Menopausal Period on Vulvovaginal Atrophy and Dyspareunia: A Systematic Review and Meta-analysis Study. J CLIN MED KAZ. 2026;23(3):31-9. https://doi.org/10.23950/jcmk/18598

REFERENCES

  • Gandhi J, Chen A, Dagur G, Suh Y, Smith NL, Cali B, Khan SA. Genitourinary syndrome of menopause: An overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American Journal of Obstetrics & Gynecology. 2016;215(6):704–711. https://doi.org/10.1016/j.ajog.2016.07.045
  • Liu M, Li F, Zhou Y, Cao Y, Li S, Li Q. Efficacy of CO₂ laser treatment in postmenopausal women with vulvovaginal atrophy: A meta-analysis. International Journal of Gynecology & Obstetrics. 2022;158(2):241–251. https://doi.org/10.1002/ijgo.13973
  • Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, Kingsberg SA. Impact of vulvovaginal health on postmenopausal women: A review of surveys on symptoms of vulvovaginal atrophy. International Journal of Women’s Health. 2013;5:437–447. https://doi.org/10.2147/IJWH.S44579
  • Ni Y, Lian J. Carbon dioxide laser therapy for the management of genitourinary syndrome of menopause: A meta-analysis of randomized controlled trials. Experimental and Therapeutic Medicine. 2024;27:10. https://doi.org/10.3892/etm.2023.12297
  • Palacios S, Mejía A, Neyro JL. Treatment of the genitourinary syndrome of menopause. Climacteric. 2015;18(Suppl 1):23–29. https://doi.org/10.3109/13697137.2015.1079100
  • ACOG Committee Opinion No. 659. The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstetrics & Gynecology. 2016;127(3):e93–e96. https://doi.org/10.1097/AOG.0000000000001331
  • Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017;99:10–15. https://doi.org/10.1016/j.maturitas.2017.01.012
  • Patel CKN. Continuous-wave laser action on vibrational-rotational transitions of CO₂. Physical Review. 1964;136(5A):A1187–A1193. https://doi.org/10.1103/PhysRev.136.A1187
  • Omi T, Numano K. The role of the CO₂ laser and fractional CO₂ laser in dermatology. Laser Therapy. 2014;23(1):49–60. https://doi.org/10.5978/islsm.14-RE-01
  • Gaspar A, Addamo G, Brandi H. Vaginal fractional CO₂ laser: A minimally invasive option for vaginal rejuvenation. American Journal of Cosmetic Surgery. 2011;28(3):156–162. Available at: https://www.monalisatouch.ch/wp-content/uploads/V2LR_Gaspar_et_al_AJCS_2011.eng_.pdf
  • Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M. A 12-week treatment with fractional CO₂ laser for vulvovaginal atrophy: A pilot study. Climacteric. 2014;17(4):363–369. https://doi.org/10.3109/13697137.2014.899347
  • Salvatore S, Maggiore ULR, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M. Microablative fractional CO₂ laser improves dyspareunia related to vulvovaginal atrophy: A pilot study. Journal of Endometriosis. 2014;6(3):150–156. https://doi.org/10.5301/je.5000184
  • Mension E, Alonso I, Tortajada M, Matas I, Gómez S, Ribera L, Anglès S, Castelo-Branco C. Vaginal laser therapy for genitourinary syndrome of menopause: A systematic review. Maturitas. 2022;156:37–59. https://doi.org/10.1016/j.maturitas.2021.06.005
  • Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, Marotta F, Calligaro A. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers in Medical Science. 2015;30:429–436. https://doi.org/10.1007/s10103-014-1677-2
  • Di Donato V, D’Oria O, Scudo M, Prata G, Fischetti M, Lecce F, Schiavi MC, Panici PB. Safety evaluation of fractional CO₂ laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study. Maturitas. 2020;135:34–39. https://doi.org/10.1016/j.maturitas.2020.02.009
  • Perino A, Calligaro A, Forlani F, Trezza V, Falcone V, Cucinella G. Vulvo-vaginal atrophy: A new treatment modality using thermo-ablative fractional CO₂ laser. Maturitas. 2015;80(3):296–301. https://doi.org/10.1016/j.maturitas.2014.12.006
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Physical Therapy. 2009;89(9):873–880. https://doi.org/10.1371/journal.pmed.1000097
  • The Joanna Briggs Institute. Critical appraisal tools for use in JBI systematic reviews. Available at: https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Systematic_Reviews2017_0.pdf
  • Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Systematic reviews of effectiveness. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. Adelaide: JBI; 2024. https://doi.org/10.46658/JBIMES-24-03
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557
  • Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to Meta-Analysis. Chichester: John Wiley & Sons; 2021. https://doi.org/10.1002/9780470743386
  • Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. https://doi.org/10. 1136/bmj.315.7109.629
  • *Eder SE, Heidinger C, Hanzal E. Early effect of fractional CO₂ laser treatment in post-menopausal women with vaginal atrophy. Laser Therapy. 2018;27(1):41–47. https://doi.org/10.5978/islsm.18-OR-04
  • *Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S. Microablative fractional CO₂ laser therapy and the genitourinary syndrome of menopause: An observational study. Maturitas. 2016;94:131–136. https://doi.org/10.1016/j.maturitas.2016.09.012
  • *Ruanphoo P, Bunyavejchevin S. Treatment for vaginal atrophy using microablative fractional CO₂ laser: A randomized double-blinded sham-controlled trial. Menopause. 2020;27(8):858–863. https://doi.org/10.1097/GME.0000000000001542
  • *Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Maggiore LR. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Climacteric. 2015;18(2):219–225. https://doi.org/10.3109/13697137.2014.975197
  • *Salvatore S, Pitsouni E, Grigoriadis T, Zacharakis D, Pantaleo G, Candiani M, Athanasiou S. CO₂ laser and the genitourinary syndrome of menopause: A randomized sham-controlled trial. Climacteric. 2021;24(2):187–193. https://doi.org/10.1080/13697137.2020.1829584
  • *Siliquini GP, Tuninetti V, Bounous VE, Bert F, Biglia N. Fractional CO₂ laser therapy: A new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric. 2017;20(4):379–384. https://doi.org/10.1080/13697137.2017.1319815
  • *Page AS, Verbakel JY, Verhaeghe J, Latul YP, Housmans S. Laser versus sham for genitourinary syndrome of menopause: A randomized controlled trial. BJOG. 2022;130:312. https://doi.org/10.1111/1471-0528.17335
  • *Tenerowicz AR, Zimmer-Stelmach A, Zimmer M. CO₂ ablative laser treatment in perimenopausal patients with vulvovaginal atrophy. Ginekologia Polska. 2022;93(5):374–380. https://doi.org/10.5603/gp.a2021.0140
  • Portman DJ, Gass MLS. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy. Journal of Sexual Medicine. 2014;11(12):2865–2872. https://doi.org/10.1097/gme.0000000000000329
  • U.S. Food and Drug Administration. FDA warns against using lasers for vaginal rejuvenation. Available at: https://www.docwirenews.com/post/fda-issues-warning-against-vaginal-rejuvenation-procedures
  • Sarmento ACA, Lírio JF, Medeiros KS. Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review. International Journal of Gynecology & Obstetrics. 2020;153(2):200–219. https://doi.org/10.1002/ijgo.13561
  • Prodromidou A, Zacharakis D, Athanasiou S, Kathopoulis N, Varthaliti A, Douligeris A, Michala L, Athanasiou V, Salvatore S, Grigoriadis T. CO₂ laser versus sham control for the management of genitourinary syndrome of menopause: A systematic review and meta-analysis of randomized controlled trials. Journal of Personalized Medicine. 2023;13(12):1694. https://doi.org/10.3390/jpm13121694
  • Purzand B, Rokhgireh S, Zanjani MS, Eshraghi N, Mohamadianamiri M, Esmailzadeh A, Alkatout I, Gitas G, Allahqoli L. Comparison of soybean and fish oil supplementation on menopausal symptoms in postmenopausal women: A randomized double-blind placebo-controlled trial. Complementary Therapies in Clinical Practice. 2020;41:101239. https://doi.org/10.1016/j.ctcp.2020.101239
  • Royal College of Nursing. Menopause guidance for nurses, midwives and health visitors. 2020. Available at: https://www.rcn.org.uk/library/-/media/Royal-College-Of-Nursing/Documents/Publications/2025/August/012-073.pdf
  • Filippini M, Porcari I, Ruffolo AF, Casiraghi A, Farinelli M, Uccella S, Franchi M, Candiani M, Salvatore S. CO₂-laser therapy and genitourinary syndrome of menopause: A systematic review and meta-analysis. Journal of Sexual Medicine. 2022;19(3):452–470. https://doi.org/10.1016/j.jsxm.2021.12.010
  • Salvatore S, Pitsouni E, Del Deo F, Athanasiou S, Grigoriadis T, Candiani M. Sexual function in women suffering from genitourinary syndrome of menopause treated with fractionated CO₂ laser. Sexual Medicine Reviews. 2017;5(4):486–492. https://doi.org/10.1016/j.sxmr.2017.07.003